Meet James Sandor Hurvitz, MD

James Sandor Hurvitz, MD is a California licensed physician, providing Medical Marijuana evaluations.

Curriculum Vitae including:
(1) Summary of Training & Qualifications
(2) Detailed Training and Qualifications
(3) Bibliography
(4) Biographical Narrative

Universities and Hospitals Dates Degrees and Training
UCLA 1964-1968 B.A.
USC School of Medicine 1969-1973 M.D.
Ohio State University Hospital 1973-1974 General Surgery Residency
Wadsworth Veterans Hospital 1974-1977 General Surgery Residency
University of Missouri Medical Center 1977-1978 Microvascular Surgery
Fellowship University of Missouri Medical Center 1978-1979 Plastic Surgery Residency
University of Texas Medical Branch (UTMB)
Shriners Burn Hospital, Galveston TX
UTMB Burn Unit, Galveston TX
1979-1982 Plastic, Reconstructive & Maxillofacial Surgery Residency
Burn Care SpecialistResidency
Burn Care Specialist Residency
American Board of Plastic
Surgery 1985 Board Certified Plastic
Surgeon Cosmetic Surgery Fellowship Miami, FL
1981 Tom Baker MD & Howard Gordon MD

DETAILED TRAINING AND QUALIFICATIONS
Primary Specialty: Plastic Surgery
Certification:Board Certified by American Board of Plastic Surgery
Sub Specialties: Reconstructive Surgery
Maxillofacial Surgery
Hand Surgery
Burn Surgery
Microvascular Surgery

MEDICAL SCHOOL ATTENDED: KECK USC SCHOOL OF MEDICINE
GRADUATION DATE: 1973
LOCATION: LOS ANGELES, CA
INTERNSHIP FACILITY 1: OHIO STATE UNIVERSITY HOSPITAL
START DATE 1: 07/1973
END DATE 1: 06/1974
TYPE 1: GENERAL SURGERY INTERNSHIP
CITY 1: COLUMBUS
STATE 1: OHIO
RESIDENCY FACILITY 1: WADSWORTH VETERANS HOSPITAL
START DATE 1: 07/1974
END DATE 1: 06/1977
SPECIALTY 1: General Surgery
CITY 1: LOS ANGELES RESIDENCY
STATE 1: CA
RESIDENCY FACILITY 2: CHILDRENS HOSPITAL
START DATE 2: 06/1975
END DATE 2: 12/1976
SPECIALTY 2: Pediatric Surgery
CITY 2: LOS ANGELES
STATE 2: CA
RESIDENCY FACILITY 3: UNIVERSITY OF MISSOURI MEDICAL CENTER
START DATE 3: 07/1977
END DATE 3: 06/1979
SPECIALTY 3: Plastic Surgery
CITY 3: COLUMBIA RESIDENCY
STATE 3: MO
RESIDENCY FACILITY 4: UNIVERSITY OF TEXAS MEDICAL BRANCH
START DATE 4: 07/1979
END DATE 4: 06/1982
SPECIALTY 4: Plastic, Reconstructive and Maxillofacial Surgery
CITY 4: GALVESTON
STATE 4: TX
FELLOWSHIP FACILITY 1: UNIVERSITY OF MISSOURI MEDICAL CENTER
START DATE 1: 07/1977
END DATE 1: 06/1979
SPECIALTY 1: Microvascular Surgery Fellowship
STATE 1: MO

BOARD CERTIFIED by AMERICAN BOARD OF PLASTIC SURGERY
PREVIOUS PRACTICE
I am Board Certified by the American Board of Plastic Surgery, & Diplomat American Board of Plastic Surgery and had been in practice specializing in Plastic, Reconstructive and Maxillofacial Surgery. My practice included Aesthetic Surgery, Pediatric Plastic Surgery, Surgery of the Hand, Industrial Hand Injuries, Microsurgery, Acute and Reconstructive Burn Care and Surgery, and Decubitus Surgery.

MEMBERSHIPS
I had been a member of multiple medical and surgical societies, including:
1. California Society of Plastic Surgeons
2. American Burn Association
3. Bay District Medical Association
4. California Medical Association
5. American Medical Association
6. Lipoplasty Society of North America
7. International Society of Lypolysis and Body Contouring
8. Phi Delta Epsilon Medical Fraternity
9. Blocker—Lewis Plastic Surgery Society
10. Singleton Surgical Society
11. Plastic Surgery Society Computer Club
12. Los Angeles Plastic Surgery Society
I had also been a member of the Sigma Xi Scientific Research Society, UCLA Chapter. I was nominated and sponsored for membership in Sigma Xi by my Chief of Plastic Surgery, Doctor Stephen R. Lewis, while I was in Galveston, Texas at the University of Texas Medical Branch, because of my active and continued involvement in surgical research since 1966.

I was also a member of:
1. American Association for the Advancement of Science
2. UCLA Alumni Association and
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 4
3. USC Alumni Association.

BACKGROUND
I was born in Santa Monica, California, and grew up in the Santa Monica Bay area.

COLLEGE
After graduation from high school at the age of 16, I immediately started college at UCLA in 1964 where
I earned my B.A. degree in Zoology in 1968.

SURGICAL RESEARCH DURING COLLEGE
While still an undergraduate at UCLA, I began doing surgical research, with the first of two consecutive
Summer Surgical Research Fellowships at the Cedars-Sinai Medical Center in Los Angeles, in the
Department of Surgery, during the summers of 1966 and 1967.

1966 RESEARCH FELLOWSHIP
During my 1966 Surgical Research Fellowship at Cedars-Sinai Medical Center, I investigated “‘In Vivo’ Staining of the Parathyroid Glands and Pancreas” using Toluidine Blue, in an animal study. Toluidine Blue is a quinone imine histologic stain that has the property of concentrating in the
parathyroid glands and pancreas, and is also secreted by the fundus of the stomach. This concentrating property of Toluidine Blue, in the parathyroid glands and pancreas, facilitates the identification of the parathyroid glands, and ectopic pancreatic tissue, during surgery.

The results of this study were reported in Archives of Surgery, 95:274-277, August, 1967

(BIBLIOGRAPHY, #1)
The clinical implications of this study were significant. If the phenomenon of concentration of Toluidine Blue in the parathyroid glands and pancreas was transferable to man, then Toluidine Blue might aid in the gross identification of the parathyroid glands and ectopic pancreatic tissue during surgery, as well as be of value for the development of a scanning agent for the parathyroid glands. Subsequently, Toluidine Blue was also found to be efficacious clinically as an aid for identifying the parathyroid glands during neck surgery.

1967 RESEARCH FELLOWSHIP:
During my 1967 Surgical Research Fellowship at Cedars-Sinai Medical Center I developed a technique, using Methylene Blue, for supravitalstaining of nerves which could aid in the gross identification of small nerve branches during surgery. This staining phenomenon was applicable as an aid for the gross identification of the recurrent laryngeal nerve during neck surgery as well as an aid for the gross identification of branches of the Vagus nerve during super selective vagotomy.

CONTINUED SURGICAL RESEARCH:
Indeed, I continued doing surgical research over the next 34 years since I first began with my first Surgical Research Fellowship at the Cedars-Sinai Medical Center in 1966.

COMPUTER ASSISTED SYSTEMS:
I have developed three computer-assisted systems: being computer-assisted patient education

(BIBLIOGRAPHY #20, #24) and an automated slide duplication system (BIBLIOGRAPHY #21, #25) that I invented (The Slide Copy System: U.S. and Foreign Patents), which I shall discuss in more detail later in
this narrative.
1. The Computer Assisted Interactive (CAI) Video Patient Education Programs (PEP) and Still Image
Storage System.
2. The Computer Assisted Video Digitizer Graphics (CA—VDG) Patient Education Program (PEP) and
Patient Video Image Storage (PVIS) System.
3. The Still Video Imaging (SVI) with Computer Assisted Drawing Board (CADB) system.
I presented the CM—Video System at the 1983 Annual Meeting of the American Society of Plastic and
Reconstructive Surgeons (ASPRS), the Plastic Surgery Education Foundation (PSEF), and the American
Society of Maxillofacial Surgeons (ASMS) held in Dallas

(BIBLIOGRAPHY #20).
I presented the CA-VDG System at the 1984 Annual Meeting of the American Society of Plastic and
Reconstructive Surgeons (ASPRS), the Plastic Surgery Educational Foundation (PSEF), and the American
Association of Maxillofacial Surgeons (ASDIS) in October, 1984 in Las Vegas (BIBLIOGRAPHY #25).
I pioneered the use of Still Video Imaging (SVI) for preoperative photographic review sessions at the initial consultation, and used this service for all my patients: the Computer Assisted Drawing Board to assist in the immediate review of these still video images with the patient. I believe this technology offers a significant advantage in the ability to immediately review photographs
at the initial consultation. The use of Still Video Imaging (SVI) with Computer Assisted Drawing Board (CADS) in no way meant to imply a warranty or guarantee of postoperative outcome, but only used for illustrative purposes to discuss patient concerns and possible surgical remedy or improvement.

SLIDE COPY SYSTEM:
I presented my slide duplication system (Slide Copy System) at the 1983 Annual Meeting of the American Society of Plastic and Reconstructive Surgeons (ASPRS), Plastic Surgery Educational Foundation (PSEF), and the American Society of Maxillofacial Surgeons (ASMS) (BIBLIOGRAPHY #21); and presented it once again at the 1984 Annual Meeting of the American Society of Plastic and Reconstructive Surgeons (ASPRS), the Plastic Surgery Educational Foundation (PSEF), and the American Society of Maxillofacial Surgeons (ASMS) (BIBLIOGRAPHY #25).

BIBLIOGRAPHY
Over the years I have accumulated a Bibliography with some 26 published papers and presentations and of these, I had three scientific exhibits presented at the 1984 Annual Meeting of the American Society of Plastic and Reconstructive Surgeons (ASPRS), the Plastic Surgery Educational Foundation (PSEF) and the American Society of Maxillofacial Surgeons (ASMS) in October, 1984 (BIBLIOGRAPHY #1, #26).

PRESENTATIONS AT ANNUAL MEETINGS
I had three presentations at the Annual Meeting of the American Society of Plastic and Reconstructive Surgeons (ASPRS), Plastic Surgery Educational Foundation (PSEF), and the American Society of Maxillofacial Surgeons (ASMS), in October 1984 held in Las Vegas.

My three presentations at the ASPRS/PSEF/ASMS Meeting were entitled:
1. “Computer Assisted Video Digitizer Graphics (CA-VDG) Programs: Applications In Plastic Surgery
Practice”.
2. “The Slide Copy System” (U.S. and Foreign Patents).
3. “Tourniquet-Nonclamp Technique (TNT) For Composite Tissue Transfer To The Upper And Lower
Extremities”.

Each presentation is described below:
1. “Computer Assisted Video Digitizer Graphics (CA-VDG) Programs: Applications In Plastic Surgery Practice” (BIBLIOGRAPHY #24).
Two applications of computer Assisted – Video Digitizer Graphics Programs for use in plastic surgery practice were presented in my exhibit:

These applications for CA-VDG Programs include:
a.) CA-VDG Patient Education Programs (PEP).
b) CA-VDG Patient Video Image Storage (PVIS).

CA-VADG Patient Education Programs (PEP) utilize computer programs consisting of text, as well as, computer-generated high resolution graphics (computer pictures) produced from video images produced by a digitizer (a device that converts a video image into a computer picture). The second application for CA-VDG (PVIS) enables floppy disc storage of patient photos as high resolution graphics (computer pictures). In addition, patient information such as diagnosis, operative reports, etc. can be stored.
Computer Assisted – Video Digitizer Graphics (CA-VDG) Programs are also applicable for use at medical meetings for the presentation of data.
2. “The Slide Copy System” (BIBLIOGRAPHY #25).
This is an automated slide duplication system that I invented (The Slide Copy System: U.S. and Foreign Patents) which is for both medical and nonmedical usage. This is also an automated audio-slide show system.
3. “The Tourniquet-Nonclamp Technique (TNT) For Composite Tissue Transfer to the Upper and Lower
Extremities” (BIBLIOGRAPHY #26)
The Tourniquet—Nonclamp Technique (TNT) is a new microvascular surgical technique that I developed for Composite Tissue Transfer To The Upper And Lower Extremities. With conventional techniques, microvascular composite tissue transfers to the extremities are usually lengthy (8-20 hours), may fail (10-30%) and may require reoperation (25%). In contrast to conventional methods, the Tourniquet Nonclamp Technique (TNT) allows for short
operating times (3 hours or less), as well as, possible increased flap survival, and decreased patient morbidity and surgeon fatigue. Harvesting of the flap, preparation of the recipient site, and performance of the anastomoses
(connecting of vessels) can be accomplished within one tourniquet time (maximum 2 hours). The TNT operative method is a two-team approach in which there are three phases.

Phase I, which I also call the “Ischemia Phase”, can be performed in 1-1/2 to 2 hours, and involves completion of flap harvest, recipient site preparation and the anastomoses, under tourniquet control, without the use of vessel clamps.
The use of a tourniquet obviates the need for clamps, which can cause damage to the vessel endothelium.
Curriculum Vitae

Phase II, which I also call the “I-Hyperemia Phase”, involves the release of the tourniquet, with resultant increased blood flow, which washes away thrombus, maintains anastomotic patency, and thereby aids reflow.

Phase III, which I also call the “Closure Phase”, can then be accomplished within 1/2 hour. Therefore, flap harvest, recipient site preparation and anastomoses are possible within two hours. Short operating times (3 hours or less) are thereby possible using the Tourniquet-Nonclamp Technique (TNT) for microvascular composite transfer to the extremities, and may contribute to
increased flap survival, and decrease patient morbidity and surgeon fatigue.

AMERICAN SOCIETY OF PLASTIC AND RECONSTRUCTIVE SURGEONS METTING 1982
In 1982, 1 had a videotape presentation at the Annual ASPRS/PSEF/ASMS Meeting (BIBLIOGRAPHY #19) entitled “Composite Tissue Reconstruction Of A Patient With Electrical Injuries To All Four Extremities”. “A male sustained electrical injuries to both arms and legs. Two tensor fasciae latae and two
latissimusDorsimyocutaneous “free flap” transfers were performed to reconstruct his four extremities. Utilizing a double team approach, and the Tourniquet—Nonclamp Technique (TNT) which I developed, each of these four “free flaps” were completed in three hours or less of operating time.
The patient is now able to walk, and drive a car. This patient is most significant, firstly, since many would have considered him a candidate for amputation. Secondly, each of his “free flap” surgeries were accomplished in very short time intervals (3 hours or less) using my Tourniquet-Nonclamp Technique (TNT). Thirdly, it is most unusual for one patient to have four “free flap” procedures.

AMERICAN SOCIETY OF PLASTIC AND RECONSTRUCTIVE SURGEONS METTING 1984
At the 1984 Annual Meeting of the ASPRS/PSEF/ASMS in Las Vegas, I presented an exhibit of my “Tourniquet-Nonclamp Technique (TNT) For Composite Tissue Transfer To The Upper And Lower
Extremities”.

AMERICAN SOCIETY OF PLASTIC AND RECONSTRUCTIVE SURGEONS METTING 1983
In 1983, I had four presentations at the annual meeting of the American Society of Plastic and Reconstructive Surgeons (ASPRS), the Plastic Surgery Educational Foundation (PSEF), and the American
Society of Maxillofacial Surgeons (ASMS), which was held in Dallas,Texas:
1. Computer Assisted Interactive (CAl) Video Programs: Applications In Plastic Surgery Practice”
2. ‘The Super—Duper: A New Automated Slide Duplication System”
3. “Transcutaneous p02Monitoring For The Assessment Of Flap Viability”
4. “Efficacy OfHyaluronidase Augmented Interstitial Diffusion (AID) For The Treatment Of IschemicFlaps” Each of my four presentations at the 1983 ASPRS/PSEF/ASMS Meeting is described below:
1. ~ Assisted Interactive (CAI) Video Programs: Applications In Plastic Surgery Practice” (BIBLIOGRAPHY #20) Computer Assisted Interactive (CAl) Video Programs utilize an interacting computer with a voice
synthesizer program working in tandem with a video program.
Two applications of CAI—Video Programs that I developed and presented are:
a. Patient Education Programs (PEP), where the patient is an active participant, and can choose which questions he or she desires answered, using a specific CAI-Video Program.
b. Still Image Storage (SIS) of patient photographs on videotape, which can be accessed on demand using a specific CAI-Video Program.
2. “The Super—Duper: A New Automated Slide Duplication System” (BIBLIOGRAPHY #21) This is the slide duplication system that I invented and patented. I held some 16 U.S. and foreign worldwide patents on The Slide Copy System.
3. Efficacy of Transcutaneous p02 Monitoring for the Assessment of Flap Viability” (BIBLIOGRAPHY #22) The purpose of this study was to determine the efficacy of transcutaneous p02 monitoring for the assessment of flap viability. I performed both animal and clinical studies.
The animal studies were encouraging, seeming to indicate a correlation between adequate transcutaneous p02 readings and survival.
The clinical data, however, demonstrated that the transcutaneous p02 determinations may be zero (or very low, i.e., 1-39) for up to two weeks in flaps that survive. Therefore, the data seems to indicate clinically transcutaneous p02 monitoring may not be efficacious when low p02 readings are present; and that the flow determination (milliwatts) may be
a better parameter to follow for assessing flap viability.My fourth presentation at the 1983 ASPRS/PSEF/ASD4S Meeting was:
4. “Efficacy of Hyaluronidase Augmented Interstitial Diffusion (AID) for the Treatment of Ischemic Flaps” (BIBLIOGRAPHY #23)
Knowing that Hyaluronidase, by augmenting interstitial diffusion (AID) increases ischemic myocardium survival (Braunwald, 1978; Kloner, 1978), and is efficacious in peripheral vascular disease (Elder,1980) led to my study of its effect upon ischemic flaps.

An animal study was performed using Sprague Daley rats, in which proximally based dorsal random
flaps were raised. Three groups had a plastic film (barrier) placed between the flap and the bed to isolate the flap from any effect the bed may have upon it.
Three groups had Hyaluronidase administered intraperitoneally. The data generated indicated that Hyaluronidase augmented flap survival, when it was started six days preoperatively, in the group with a barrier in place.

The clinical implications of this study are most significant.

They are that Hyaluronidase may be of
use for:
1) Salvaging ischemic flaps
2) Prophylaxis against flap ischemia
3) For a “Chemical Delay”
4) For synergism with other drugs to augment tissue survival
5) For non-microvascular composite tissue reimplantation

1984 ASPRS/PSEF/ASMS MEETING
As I have mentioned above, at the 1984 meeting of the American Society of Plastic and Reconstructive Surgeons (ASPRS), the Plastic Surgery Education Foundation (PSEF), and the American Society of Maxillofacial Surgery (ASMS), in October, 1984, I had three presentations:
1. “Computer Assisted – Video Digitizer Graphic (CA-VDG) Programs: Application in Plastic Surgery
Practice” (BIBLIOGRAPHY #24)
2. “The Slide Copy System (U.S. and Foreign Patents)” (BIBLIOGRAPRY #25)
3. “The Tourniquet-Nonclamp Technique (TNT) For Composite Tissue Transfer To The Upper And
Lower Extremities” (BIBLIOGRAPHY #26)

MEDICAL SCHOOL
I received my M.D. degree from the University of Southern California, School of Medicine in 1973, where I held a clinical teaching appointment at the Los Angeles County – USC Medical Center in the Division of Plastic Surgery of the Department of Surgery.

EXTERNSHIPS
While I was a medical student at USC, I did three months of externship abroad. I did an internal medicine externship in London at Kings College Hospital; as well as, a surgical externship at Beilinson Hospital, in Tel Aviv, Israel.

SURGICAL RESEARCH IN MEDICAL SCHOOL
Also, I continued doing surgical research while I attended the USC School of Medicine.
GRANT I received a grant from the McGaw Pharmaceutical Laboratories for research during a Research Elective at the USC School of Medicine.
The research subjects I investigated with my research grant were:
Further work was done on ‘in vivo’ staining of the parathyroid glands and pancreas using Toluidine Blue (BIBLIOGRAPHY #1). Attempts were made to label Toluidine Blue with a radionuclide in an attempt to develop a new scanning agent for the parathyroid glands (BIBLIOGRAPHY #1).
One of the clinical implications of Toluidine Blue concentration in the parathyroid glands is the possible use of labeled Toluidine Blue as a scanning agent for the parathyroid glands.

POSTGRADUATE SURGICAL TRAINING(9 YEARS)
I then did a total of nine years of postgraduate surgical training, including four years of General and Pediatric Surgery Residency, and five years of Residency in Plastic, Reconstructive and Maxillofacial Surgery, Cosmetic Surgery, Pediatric Plastic Surgery, Surgery of the Hand and Industrial Hand Injuries,
Microsurgery, Burns and Decubitus Surgery; which included a one-year Fellowship in Microvascular Surgery, as well as, a Cosmetic Surgery Fellowship. All through my Postgraduate Surgical Training, I continued doing surgical research, and presenting and publishing papers.

INTERNSHIP
I did a surgical internship at Ohio State University Hospital 1973 to 1974, where my chief was Doctor Robert Zollinger. It was indeed a privilegeand rare experience learning surgery from such a renowned surgeon as Doctor Zollinger. Doctor Zollinger instilled in me a sound basis in General Surgery and a determination to strive for excellence, which has held me in good stead in my specialty of Plastic Surgery.

PEDIATRIC SURGERY
At Ohio State, I also had Pediatric Surgical Training at Columbus Children’s Hospital.

AWARDS
During my internship at Ohio State, I received Honorable Mention in the 1973 Residency Essay contest Sponsored by the American College of Surgeons.
In my essay, I reported on original research I did on “‘In Vivo’ Staining And Scanning Of The Parathyroid Glands And Pancreas”, including my attempts to develop a new scanning agent for the parathyroid glands using Toluidine Blue labeled with the radionuclide Technetium.
Hurvitz, et al.: “‘In Vivo’ Staining of The Parathyroid Glands And Pancreas”. Arch. Surg. 95:274—
277, Aug., 1967.

GENERAL AND PEDIATRIC SURGERY POSTGRADUATE TRAINING AND RESEARCH GENERAL SURGERY
In Los Angeles and I did General Surgery Residency at the Wadsworth Veterans Administration Hospital Medical Center 1974 to 1977.

SURGICAL RESEARCH
I continued doing Surgical Research during my General Surgery Residency. Research studies that I pursued during that time were: Aortic grafts were placed in dogs and the incidence of aortoduodenal fistula was studied in infected versus non-infected grafts.

Further work was done in dogs in trying to develop a new scanning agent for the parathyroid glands and pancreas using Toluidine Blue labeled with Technetium.

An animal study was performed using dogs investigating the relationship between renin release and renal cortical ischemia following cross clamping of the aorta.

PEDIATRIC SURGERY
While in my General Surgery Residency, I did a Six-month term of Pediatric Surgery Residency Training at the Children’s Hospital of Los Angeles.
PLASTIC SURGERY POSTGRADUATE TRAINING, MICROVASCULAR SURGERY, COSMETIC SURGERY FELLOWSHIPS AND RESEARCH Interesting enough, it was while I was at Children’s Hospital of Los Angeles that I committed myself to Plastic Surgery, after working with the Plastic Surgery Attending Staff who really introduced me to Plastic Surgery via the vehicle of Pediatric Plastic Surgery. What attracted me to Plastic Surgery was the wide clinical diversity of the specialty of Plastic, Reconstructive and Maxillofacial Surgery, including Cosmetic Surgery, Surgery of the Hand and Industrial Hand Injuries, Pediatric Plastic Surgery both congenital and traumatic; the many aspects of Microsurgery including Replantation, composite tissue Transfer, Microneural Surgery and Microlymphovenous
Surgery; as well as Acute and Reconstructive Burn Care; and the reconstruction of all manner of difficult wounds both soft tissue and bone whether traumatic or surgical.

Also, the magnitude of possible research areas attracted me to Plastic Surgery as well. I developed an intense interest in Plastic Surgery in the pediatric age group after my first exposure to itat Children’s Hospital of Los Angeles. My keen interest in pediatric plastic surgery has continued until
this day.

PEDIATRIC SURGERY PAPER, PUBLISHED AND PRESENTED
While I was at Children’s Hospital of Los Angeles, I presented and published a paper of a case report of an aneurysmal bone cyst of the rib, mimicking a Ewing’s sarcoma in a child of 14 years. I presented the paper at the Annual American Pediatric Association, 1977, in Acapulco (BIBLIOGRAPHY
#11):Hurvitz, .1.5., et al.: Aneurysmal Bone Cyst Of The Rib Mimicking Ewing’s Sarcoma of The Rib.American Pediatric Surgical Association 8th Annual Meeting,Acapulco, Mexico, April 20—23, 1977. The paper was published in the Journal of Pediatric Surgery (BIBLIOGRAPHY #2):
Hurvitz, 5.5., et al.: Aneurysmal Bone Cyst Mimicking Ewing’s Sarcoma Of The Rib. Jour. Ped. Surg. 12(6)1067—1069, Dec. 1977.

“A cantaloupe size intrathoracic tumor destroying the 8th rib with pleural effusion in a 14 yearold boy with a 10—pound weight loss is ominous.
The standard treatment is en bloc full thickness chest wall resection. Exploratory right thoracotomy revealed a large intrathoracic mass protruding from the chest wall over the 8th rib with an adherent right lower lobe.
Adequate surgical extirpation would have required radical en bloc full thickness chest wall resection of at least six ribs and chest wall reconstruction. Since radiotherapy and chemotherapy might shrink the suspected Ewing’s sarcoma, and allow less destructive extirpation, the chest wall was closed and the tumor biopsied from the outside of the 8th rib. When the permanent sections demonstrated a benign tumor consistent with aneurysmal bone
cyst, complete resection of the tumor was performed with partial resection of the 8th and 9th ribs and wedge resection of the adherent right lower lobe. No chest wall reconstruction was necessary and the boy had no functional deficit.
Final diagnosis was aneurysmal bone cyst of the rib, only the second case reported in the world medical literature. The clinical presentation, radiographic and intraoperative appearance of this benign aneurysmal bone cyst mimicked a Ewing’s sarcoma. Conservatism in the initial surgical
approach to this tumor was the key to avoiding an unnecessarily debilitating
radicalprocedure.Aneurysmal bone cyst is a rare lesion worth considering in the differential diagnosis of bone—destroying lesions in children.”

MICROVASCULAR SURGERY FELLOWSHIP (1YEAR)
After deciding upon a career in plastic surgery, I decided to begin my Plastic Surgery Training with a Microvascular Surgery Fellowship at the University of Missouri Medical Center in the Division of Plastic Surgery.
I was a Fellow in the Division of Plastic Surgery at the University of Missouri Medical Center, Columbia, Missouri for one year, during which time I was a Research Associate in Microvascular Surgery. My research during my Microvascular Fellowship generated six published papers, and four papers
delivered at national and international meetings. (BIBLIOGRAPHY #3, #4, #5, #6, #7, #8, #12, #13, #14 and #15):
1).Puckett, C.L. and Hurvitz, J.S.; et al.: Studies Of Bone Formation By MicroRevascularizedPeriosteumCompared With Traditional Bone Grafts. Surg. Forum 29:609-610, 1979.(BIBLIOGRAPHY #3)
2) Puckett, C.L. and Hurvitz, J.S.; et al.: Comparative Evaluation Of Bone FormationByMicrorevascularizedPeriosteum And Bone Grafts With Traditional Bone Grafts. Plas.& Recon.Surg.64:361-365, Sept., 1979 (BIBLIOGRAPHY #14)This paper is a part of the Selected Readings in Plastic Surgery Series.
3) Hurvitz, J.S. and Puckett, C.L.: A Suction Regulator ForMicrovascular Surgery. Plas.& Recon. Surg.
63:583, Apr., 1979. (BIBLIOGRAPHY #5)
4) Puckett, C.L.: Jacobs, G.R.; and Hurvitz, J.S.; and Silver, D.:Evaluation Of Lymphovenous
Anastomoses In Obstructive Lymphedema. Plas. Surg. Forum, Vol.
11:123, 1979. (BIBLIOGRAPHY #6)
5) Puckett, C.L.; Jacobs, G.R.; Hurvitz, 3.8.; and Silver, ID.: Evaluation OfLymphovenous
Anastomoses In Obstructive Lymphedema. Plas.& Recon. Surg. 66:116-120, July, 1980.
(BIBLIOGRAPHY #7)
6) Puckett, C.L. and Hurvitz, J.S.; etal.: Studies Of Bone Formation By MicroRevascularizedPeriosteum Compared With Traditional Bone Grafts. 64th Annual Clinical Congress,
American College Of Surgeons, Surgical Forum, San Francisco,1978. (BIBLIOGRAPHY #12)
7) Puckett, C.L. and Hurvitz, J.S.; et al.: Comparative Evaluation Of Bone Formation By MicroRevascularizedPeriosteum And Bone Grafts. 49th Annual Convention of the American Society of
Plastic and Reconstructive Surgeons, Plastic Surgery Educational Foundation, and the American
Society of Maxillofacial Surgeons,1980. (BIBLIOGRAPHY #13)
8) Puckett, C.L. and Hurvitz, J.S.; et al.: Evaluation Of Bone Formation By Micro—Revascularized
Periosteum And Bone Grafts Compared With Traditional Bone Grafts. World Micro—Surgical
Congress, Bonn, Germany, 1978. (BIBLIOGRAPHY #14)
9) Hurvitz, 3.S. and Puckett, C.L.; et al.: Evaluation OfLymphovenous Anastomoses In Obstructive
Lymphedema. Annual Meeting of the Missouri Chapter,
American College of Surgeons, June, 1979. (BIBLIOGRAPHY #15)

MICROVASCULAR FELLOWSHIP RESEARCH
My research during my Microvascular Fellowship included:
#1) A study of bone formation by revascularized periosteal grafts and bone grafts compared with
traditional bone grafts. (BIBLIOGRAPHY #3, #4, #12, #13 and #14)
“I was interested in studying the different modalities for treatment of boney defects in “unstressed
bone” including: traditional bone grafts,microrevascularizedbone grafts, and the newest modality,
periosteal grafts. I wanted to compare the strength and quality of bone formed by each graft
modality in “unstressed bone”, as might be applicable to head and neck reconstruction (skull and
facial bones).
The “unstressed” bone model chosen was the dog fibula. I compared traditional (non—
revascularized) bone grafts; microrevascularized bone grafts; non—revascularized periosteal grafts;
and microrevascularized periosteal grafts.
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 16
My findings were most interesting. Both microrevascularizedperiosteum and non—
revascularizedperiosteum had no potential to form structurally significant bone in boney defects
unsubjected to physical stress, i.e. in ‘unstressed bone”. This would seem to obviate its potential for
on—lay or interpositionalreconstruction of defects in the skull or facial
bones.Themicrorevascularized rib grafts had a slightly greater Tolerance to stress at the callus than
traditional bone grafts, but the incidence of non—union was the same.
Therefore, the use of revascularized bone grafts should be reserved f or situations in which
traditional bone grafting techniques are unlikely to be successful.”
#2) Evaluation of lymphovenous anastomoses in obstructive lymphedema. (BIBLIOGRAPHY #6, #7, #15)
“Obstructive lymphedema is a very difficult problem to treat, as evidenced by the many treatment
modalities that have been proposed and advocated.
One such modality is “lymphovenous anastomosis”, i.e., anastomosing a lymphatic vessel to a vein
using the operating microscope in an attempt to rid the limb of
lymphedema fluid.
Although there were both animal and clinical studies in the literature reporting the use of
lymphovenous anastomoses, in none of these studies was an attempt made to actually correlate the
incidence of ‘anastomotic patency’ with the ‘degree of lymphedema’ in an animal or clinical subject
that actually had obstructive lymphedema. Hence, the purpose of my study.Direct lymphovenous
anastomoses were constructed in dogs with obstructive lymphedema.
Patency of the lymphovenous anastomoses was determined by direct observation at time intervals
after lymphovenous anastomoses were performed. The patency was correlated with the effect on
the course of the lymphedema. Early patency rates of the lymphovenous anastomoses were
occluded. Long time patency was not maintained. The explanation for this is that effective
decompression of the lymphovenousanastomoses results in decreased flow through the
anastomoses which leads to occlusion.
The clinical implication of this study is that, perhaps the same turn of events is occurring clinically,
and that perhaps any improvement noted clinically results from the use of concomitant conservative
measures such as elevation and compression therapy.”
#3) Efficacy of intra—arterial Reserpine for the treatment of intra—arterial.injection injuries.
“Reserpine (3, 4, 5—trimethoxybenzoyl methyl reserpate), which is an active alkaloid from various
species of Rauwolfia, and which is used as an antihypertensive, tranquilizer and sedative, was
studied as a possible treatment for intra—arterial injection injuries. Intra—arterial injection of many
substances can have disastrous consequences which can result in loss of parts of extremities.
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 17
The efficacy of intra—arterial Reserpine was studied as a possible treatment modality for intra—
arterial injection injuries in dogs.
Intra—arterial Reserpine was not found to be efficacious in the treatment of intra—arterial injection
injuries in dogs.”
#4) The role of fibrinolysis in the “no-reflow phenomenon”.
“When blood flow is disrupted from tissue, it can be re-established up until a certain time has
passed.
Beyond that certain time, blood flow cannot be re-established. This is the “no reflow phenomenon”.
It appears to be a multifactorial phenomenon. One factor that is involved is “fibrinolysis”. A decline
of fibrinolysis activity during the time blood flow is disrupted appears to be involved in the “no
reflow phenomenon.”
#5) Efficacy of Hyaluronidase Injection Therapy (HIT) for the treatment of Adriamycin extravasation
injuries.
“The extravasation of the chemotherapeutic agent, Adriamycin, during intravenous administration
of the drug, can cause a severe necrotic wound.
I was interested in studying the potential value of augmenting the interstitial diffusion of the drug
from the extravasation site using Hyaluronidase, in an attempt to avoid the usual necrotic wound
resulting from extravasation.
I was later awarded an American Cancer Society grant to study this problem at the University of
Texas Medical Branch in Galveston.
At these initial studies, the efficacy of Hyaluronidase for Adriamycin extravasation injuries was
investigated.
I have subsequently demonstrated the efficacy of Hyaluronidase Injection Therapy (HIT) for the
treatment of extravasations of caustic and hyperosmolar substances in infants (BIBLIOGRAPHY
#18).”
#6) A simplified method of photography through the operating microscope.
“My operating microscope did not have a photomicrography camera tube attachment and I needed
to photomicrographically document my microvascular research.
Therefore, I developed a technique of photomicrography through the operating microscope ocular
utilizing a standard 35mm camera with a 50mm macro lens.”
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 18
#7) The development of a suction regulator for use in micro— vascular surgery (BIBLIOGRAPHY #5)
“This is another of my inventions that I developed during my Microvascular Surgery Fellowship,
which allowed for a controlled, low level, sate suction that I expressly designed for use
inmicrovascular surgical procedures.
The normal line suction in the operating room is much too great for use in microvascular procedures
and can in fact be damaging. I published a description and picture of my suction regulator in Plastic
and Reconstructive Surgery in 1979.”
UNIVERSITY OF MISSOURI MEDICAL CENTER
I then spent an additional year in the Division of Plastic Surgery at the University of Missouri Medical
Center in Columbia, Missouri, including training at the University Hospital, RuskRehabilitation Hospital in
Columbia, as well as the Veterans Administration Hospital in Columbia.
During my Surgical Postgraduate Training at the University of Missouri Medical Center, I obtained
experience in Plastic, Reconstructive and Maxillofacial Surgery, Cosmetic Surgery, Pediatric Plastic
Surgery, Surgery of the Hand including Industrial Hand Injuries, Microsurgery and Decubitus Surgery.
My experience in Rehabilitative Reconstructive Surgery at Rusk Rehabilitation Hospital was invaluable.
I cared for many quadriplegic patients at Rusk Rehabilitation Hospital who needed rehabilitative and
reconstructive hand surgery to improve their pinch and grasp.
Rusk Rehabilitation Hospital is a large rehabilitation center for the care of multiple problems including
those of paraplegic and quadriplegic patients. I had the opportunity to, therefore, do a large amount of
decubitus surgery, as well, on these patients.
UNIVERSITY OF TEXAS MEDICAL BRANCH
Following my training at the University of Missouri Medical Center, I did an additional three years of
Plastic Surgery Training at the University of Texas Medical Branch in Galveston, in the Division of Plastic
Surgery.
BURNS
The residency included intensive Burn Training at the University of Texas Medical Branch Burn Unit and
the Shrine Burn Institute in Galveston.
BURN PRESENTATIONS (Electrical injury reconstructions)
1)Hurvitz, J.S.; et al.: Composite Tissue Reconstruction Of A Patient With Electrical Injuries To All
Four Extremities. ASPRS Meeting, October, 1982.
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 19
2) Hurvitz, J.S.: The Tourniquet-Nonclamp Technique (TNT) For Composite Tissue Reconstruction Of
The Upper And Lower Extremities. ASPRS Meeting, October, 1984.
GENERAL AND SPECIALIZED PLASTIC SURGERY
My training at the University of Texas Medical Branch (UTMB) included not only burns, but additional
experience in General and Specialized Plastic, Reconstructive and Maxillofacial Surgery, Cosmetic
Surgery, Pediatric Plastic Surgery, Surgery of the Hand and Industrial Hand Injuries, Microsurgery and
Decubitus Surgery.
MICROSURGERY
Because of my expertise in Microsurgery gained during my Microvascular Surgery Fellowship, I
organized and instructed microvascular surgery laboratory, composite tissue transfer and replantation
programs for my fellow Plastic Surgery Residents at the University of Texas Medical Branch, including
didactic, laboratory and cadaver dissection sessions for preoperative composite tissue transfer planning.
While at UTMB, I performed composite tissue transfers and replantation of parts on selected patients.
TOURNIQUET-NONCLAMP TECHNIQUE (TNT)
Also, while at UTMB, I developed the “Tourniquet-Nonclamp Technique (TNT) for Composite Tissue
Transfer to the Upper and Lower Extremities”.
AMERICAN SOCIETY OF PLASTIC AND RECONSTRUCTIVE SURGEONS MEETING 1982
In 1982, I gave a videotape presentation at the American Society of Plastic and Reconstructive Surgeons
(ASPRS), the Plastic Surgery Educational Foundation (PSEF), and the American Society of Maxillofacial
Surgeons (ASMS) Annual Meeting in Hawaii, in which I presented four extremity reconstructions of a 28
year-old man who sustained electrical injuries to all four extremities, using my Tourniquet-Nonclamp
Technique (TNT). (BIBLIOGRAPHY #19):
Hurvitz, J.S., et al: Composite Tissue Reconstruction Of A Patient With Electrical Injuries To All Four
Extremities. American Society of Plastic and Reconstructive Surgeons (ASPRS), Plastic Surgery
Educational Foundation (PSEF), and the American Society of Maxillofacial Surgeons (ASMS) 51st
AnnualMeeting. Honolulu, Hawaii, October 10-15, 1982
AMERICAN SOCIETY OF PLASTIC AND RECONSTRUCTIVE SURGERY MEETING 1984
In October of 1984, I presented an exhibit at the 1984 Annual Meeting of the American Society of Plastic
and Reconstructive Surgeons (ASPRS), the Plastic Surgery Educational Foundation (PSEF), and the
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 20
American Society of Maxillofacial. Surgery (ASMS), in which I presented my microvascular TourniquetNonclamp Technique (TNT) for composite tissue transfer to the extremeties. (BIBLIOGRAPHY #26):
1) Hurvitz, 1.5.: The Tourniquet—Nonclamp Technique (TNT) For Composite Tissue Transfer To The
Upper And Lower Extremities.
At the same meeting, I presented two more exhibits.
One exhibit was on my computer-assisted patient education system (BIBLIOGRAPHY #24):
2) Hurvitz, J.S.: Computer-Assisted video Digitizer Graphics (CA—VDG) Programs: Applications In
PlasticSurgery Practice.
The other exhibit presented my patented automated photographic slide duplication system. (I
hold some 16 U.S. and foreign worldwide patents on my Slide Copy System, that I invented.)
(BIBLIOGRAPHY #25;
3) Hurvitz, J.S.: The Slide Copy System (U.S. and foreign patents).
RESEARCH AT UNIVERSITY OF TEXAS MEDICAL BRANCH
During my Plastic Surgery Residency at University of Texas Medical Branch (UTMB) in Galveston, I
managed to also do both clinical and animal research (7 projects) and to present three more papers
describing the results of my clinical and animal research at UTMB .
The seven research subjects that I investigated and presented included:
1. Efficacy of Hyaluronidase Augmented Interstitial Diffusion (AID) For The Treatment Of Ischemic Flaps.
I presented my data at two meetings:
1. Hurvitz, .J.S.: National Student Research Forum, 1982.
2. Hurvitz, .J.S.: ASPRS/FSEF/ASMS Meeting, 1983.
2. Efficacy of Transcutaneous p02 Monitoring For The Assessment Of Flap viability.
I presented my data at two meetings:
1. Hurvitz, .J.S.: National Student Research Forum, 1982.
2. , J.S.: ASPRS/PSEF/ASMS Meeting, 1983.
3. Efficacy of Hyaluronidase Injection Therapy (TNT) For The Treatment Of Extravasation Injuries In
Infants
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 21
(This was one of two Human Research Protocol that I wrote and executed while at UTMB. The other
Human Research Protocol is described in #7 below.)
I presented my data at one meeting:
Hurvitz, J.S.: Plastic Surgery Senior Residents Conference, 1982.
4. The Tourniquet-Nonclamp Technique (TNT) For Composite Tissue Transfer To The Upper And Lower
Extremities .
I presented my data at two meetings:
1. Hurvitz, J.S.: ASPRS/PSFP/ASMS Meeting, 1982.
2. Hurvitz, J.S.: ASPRS/PSEF/ASMS Meeting, 1984.
5. The Slide Copy System
I presented my invention at two meetings:
1. Hurvitz, J.S.: ASPRS/PSEF/ASr4S Meeting, 1983.
2. Hurvitz, J.3.: ASPRS/PSEF/ASMS Meeting, 1984.
6. Efficacy of Hyaluronidase Injection Therapy (HIT) For The Treatment Of Adriamycin Extravasation
Injuries
I had an American Cancer Society Grant:
Hurvitz, J.S.: American Cancer Society Grant.
7. Efficacy of Stabilized Amniotic Membrane (SAM) As A New Biological Dressing
(This is one of two Human Research Protocols that I wrote and executed while at UTMB. The other is
described above in #3.)
HUMAN RESEARCH PROTOCOLS AT UTMB
I wrote, had approved by the Hospital Human Research Committee and executed two Human Research
Protocols while at UTMB:
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 22
1. Hurvitz, J.S.: Efficacy of HyaluronidaseInjection Therapy (HIT) For The Treatment of Extravasation
Injuries In Infants. UTMB, Galveston, 1982.
2. Hurvitz, J.S.: Efficacy Of Stabilized Amniotic Membrane (SAM) As A Biologic Dressing. UTMB,
Galveston, 1982.
GRANT RECEIVED WHILE AT UTMB
American Cancer Society, 19S2: Efficacy OfHyaluronidase Injection Therapy (HIT) For Adriamycin
Extravasation Injuries.
PAPERS PRESENTED WHILE AT UTMB
These papers included the following studies:
1.Hurvitz, 5.5.: Efficacy OfHyaluronidaseInjection Therapy (HIT) For The Treatment of Extravasation
Injuries In Infants. Plastic Surgery Senior Residents Conference, Norfolk, Virginia, May, 1982.
(BIOBLIOGRAPHY #18)
At the Plastic Surgery Senior Residents Conference I presented the results of a human research
protocol I wrote and executed on the efficacy of Hyaluronidase Injection Therapy (HIT) for the
treatment of extravasations of hyperosmolar and caustic (calcium) solutions in infants.
I determined that HyaluronidaseInjection Therapy (HIT) was indeed efficacious in preventing injury,
if treatment was instituted soon after the extravasation occurred. (BIBLIOGRAPHY #18)
“Infiltration of hypertonic and caustic intravenous fluids (D1OW, D12.5W, TPN, and calcium
gluconate) can result in necrotic wounds in infants. No efficacious treatment exists to prevent
necrosis after the extravasation has occurred. Besides augmenting interstitial diffusion,
Hyaluronidase depolymerizes ground substance mucopolysacharides into oligosacharides,
monosacharides, N-acetyl glucosamine and glucuronic acid. The ground substance viscosity
decreases and its permeability increases, thereby allowing for increased diffusion of the
extravasation from the area as well as nutrients to the extravasation site.
The date demonstrated that Hyaluronidase prevented necrosis.”
#2.Hurvitz, 3.5.: Efficacy OfHyaluronidase Augmented Interstitial Diffusion (AID) For The Treatment Of
Ischemic Flaps. National Student Research Forum, 1982.
#3.Hurvitz, 5.5.: Efficacy Of Transcutaneous p02Monitoring For The Assessment Of Flap Viability.
National Student Research Forum, 1982.
DOCTOR TRUMAN BLOCKER
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 23
It was indeed a privilege knowing and learning from Doctor Truman Blocker, a pioneer in burn care and
the founder of the UTMB Plastic Surgery Residency.
COSMETIC SURGERY FELLOWSHIP
While at UTMB, I did a Cosmetic Surgery Fellowship with Doctors T. Baker and H. Gordon in Miami,
Florida.
PRACTICE, BATON ROUGE
After completing my residency training, I went into private practice in Baton Rouge, Louisiana, for one
and one-half years.
I decided to practice in Eaton Rouge because I knew and like the area, having trained nearby in
Galveston.
PEDIATRIC PLASTIC SURGERY
Also, practicing in Baton Rouge was a great opportunity to pursue my keen interest in Pediatric
Plastic Surgery, and to do a large volume of cleft lip and palate surgery by being associated with the
Handicapped Children’s Services Program for the State of Louisiana.
GENERAL AND SPECIALIZED PLASTIC SURGERY
In addition, practice in Baton Rouge offered a broad range of surgical cases including General and
Specialized Plastic, Reconstructive and Maxillofacial Surgery, Cosmetic Surgery, Pediatric Plastic Surgery,
Surgery Of The Hand and Industrial Hand Injuries, Microsurgery, Burns and Decubitus Surgery.
1983 ASPRS/PSEF/ASMS MEETING
It was while I was in practice in Baton Rouge that I had four presentations at the 1983 American Society
of Plastic and Reconstructive Surgeons, PSEF/ASMS Meeting, which was held in Dallas Texas
(BIBLI0GRAPHY #20, #21, #22 and #23).
1. Hurvitz, J.S.: Computer Assisted Interactive (CA!) Video Programs: Applications In Plastic Surgery
Practice.
2. Hurvitz, J.S.: The Super—Duper: A New Automated Slide Duplication System (The Slide Copy
System: U.S. and Foreign Patents).
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 24
3. Hurvitz, J.S.: Efficacy of Transcutaneous p02Monitoring for the Assessment of Flap Viability.
4. Hurvitz, J.S.: Efficacy of Hyaluronidase Augmented Interstitial Diffusion (AID) for the Treatment of
Ischemic Flaps.
STATE OF LOUISIANA APPOINTMENT
As I stated, while in practice in Baton Rouge I had a Clinical Appointment from the State of Louisiana to
care for children in the Handicapped Children’s Services Program with pediatric plastic surgical
problems.
HANDICAPPED CHILDRENS SERVICES AND CLEFT PALATE TEAM
During this time, I was co-leader of the Baton Rouge Cleft Palate Team and the Handicapped Children’s
Services Program in Baton Rouge for 1-1/2 years.
During my tenure in Baton Rouge, I cared for several hundred patients and did a large volume of such
surgery as well.
I cared for not only cleft lip and palate patients, but for other congenital problems as well, such as
hemangioma.
In one notable Handicapped Children’s Services patient, a boy of nine years, I surgically excised
anhemangioma of the knee region and then did a microvascular reconstruction with a
latissimusdorsimyocutaneous “free flap”.
I used my Tourniquet-Nonclamp Technique (TNT) that I developed to do the Surgery.
MOVED TO CALIFORNIA
After three years in Galveston, and a year and a half in practice in Eaton Rouge, my tolerance for hot,
humid, rainy weather reached a limit.
I decided to permanently return to California and I joined Doctor Gerald Davis in practice in Santa
Monica. In 1984, I moved to solo practice at the Santa Monica Medical Plaza next to Saint John’s Health
Center.
I had been most pleased to be able to combine my clinical practice with my academic interests in
teaching and research by way of my clinical appointment at the University of Southern California in the
Division of Plastic Surgery of the Department of Surgery.
In addition, I had three presentations at the 1984 American Society of Plastic and Reconstructive
Surgeons Meeting held in Las Vegas, Nevada, October, 1984.
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 25
1. Hurvitz, J.S.: Computer Assisted Video Digitizer Graphics (CA—VDG) Programs: Applications In
Plastic Surgery Practice.
2. Hurvitz, J.S.: The Slide Copy System (U.S. and Foreign Patents Pending).
3. Hurvitz, J.S.: The Tourniquet-Nonclamp Technique (TNT) For Composite Tissue Transfer To The
Upper And Lower Extremities.
I have introduced myself to you by way of this Biographical Narrative describing my background,
education, previous practice, research and bibliography.
Most Sincerely,
J SandorHurvitz MD.
My Physician CV Information below summarizes my internship, residency and fellowship training.
Mybiographical Narrative above describes my background, education, previous practice, research and
bibliography.
PHYSICIAN CV INFORMATION
========================================
NAME: J SANDOR: HURVITZ MD
PHONE: 818-264-5014
EMAIL ADDRESS: jhurvitzmd@gmail.com
PRIMARY SPECIALTY: Plastic Surgery
CERTIFICATION: Board Certified by American Board of Plastic Surgery
SUB SPECIALTIES: Reconstructive Surgery,Maxillofacial Surgery , Hand Surgery, Microvascular Surgery
MEDICAL SCHOOL ATTENDED: KECK USC SCHOOL OF MEDICINE
GRADUATION DATE: 1973
LOCATION: LOS ANGELES, CA,
INTERNSHIP FACILITY 1: OHIO STATE UNIVERSITY HOSPITAL
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 26
START DATE 1: 07/1973
END DATE 1: 06/1974
TYPE 1: GENERAL SURGERY
CITY 1: COLUMBUS
STATE 1: OHIO
RESIDENCY FACILITY 1: WADSWORTH VETERANS HOSPITAL
START DATE 1: 07/1974 RESIDENCY END DATE 1: 06/1977 RESIDENCY SPECIALTY 1: General Surgery
CITY 1: LOS ANGELES
STATE 1: CA
RESIDENCY FACILITY 2: CHILDRENS HOSPITAL, LOS ANGELES
START DATE 2: 06/1975
END DATE 2: 12/1976
SPECIALTY 2: Pediatric Surgery
CITY 2: LOS ANGELES
STATE 2: CA
RESIDENCY FACILITY 3: UNIVERSITY OF MISSOURI MEDICAL CENTER
START DATE 3: 07/1977
END DATE 3: 06/1979
SPECIALTY 3: Plastic Surgery
CITY 3: COLUMBIA
STATE 3: MO
RESIDENCY FACILITY 4: UNIVERSITY OF TEXAS MEDICAL BRANCH
START DATE 4: 07/1979
END DATE 4: 06/1982
SPECIALTY 4: Plastic Surgery RESIDENCY
CITY 4: GALVESTON
STATE 4: TX
FELLOWSHIP FACILITY 1: UNIVERSITY OF MISSOURI MEDICAL CENTER
START DATE 1: 07/1977
END DATE 1: 06/197
SPECIALTY 1: Microvascular Surgery
STATE 1: MO FELLOWSHIP COUNTRY 1: USA
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 27
BIBLIOGRAPHY
CONTENTS
A. Published Papers
B. Papers Presented
C. Videotape, Exhibit and Displays Presented
A. PUBLISHED PAPERS
1.
Hurvitz, R.J.; Hurvitz, J.S.; and Morgenstern, L. :‘In Vivo’ Staining of the Parathyroid Glands and Pancreas.
Arch. Surg. 95:274-277, Aug., 1967.
2.
Hurvitz, J.S..; Harrison, M.R.; and Weitzman, J.: Aneurysmal Bone Cyst Mimicking Ewing’s Sarcoma of the
Rib. 3. Ped. Surg. 12(6): 1067-1069, Dec., 1967.
3.
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 28
Puckett, C.L.; Hurvitz, J.S.; Metzler, L.; and Silver, D.: Studies of Bone Formation by
MicrorevascularizedPeriosteum Compared With Traditional Bone Grafts. Surg. Forum 29: 609-610, 1979.
4.
Puckett, C.L.; Hurvitz, 3.5.; and Metzler, M.A.: Comparative Evaluation of Bone Formation by
MicrorevascularizedPeriosteum and Bone Grafts With Traditional Bone Grafts. Plas. & Recon. Surg.
64:361-365, Sept., 1979.
5.
Hurvitz, J.S. and Puckett, C.L.: A Suction Regulator for Microvascular Surgery. Plas. & Recon. Surg.
63:583, Apr., 1979.
6.
Puckett, C.L.; Jacobs, S.R.; Hurvitz, J.S.; and Silver, D.: Evaluation of Lymphovenous Anastomoses in
Obstructive Lymphedema. Plas. Surg. Forum, Vol. II: 123, 1979.
7.
Puckett, C.L.; Jacobs, G.R.; Hurvitz, 3.5.; and Silver, D.: Evaluation of Lymphovenous Anastomoses in
Obstructive Lymphedema. Plas. and Recon. Surg. 66:116-120, July, 1980.
8.
Hurvitz, J.S.; Blackwell, 5.3.; and Lewis, S.R.: Composite Tissue Reconstruction of a Patient With Electrical
Injuries to All Four Extremities. Plas. Surg. Forum, Vol V:125, 1982.
9.
Hurvitz, J.S.: Efficacy of Transcutaneous p02 Monitoring for the Assessment of Flap Viability. Plas. Surg.
Forum, vol.v:113—115, 1983.
10.
Hurvitz, J.S.: Efficacy of Hyaluronidase Augmented Interstitial Diffusion (AID) for the Treatment of
Ischemic Flaps. Plas. Surg. Forum, Vol. VI:96-98, 1983.
B. PAPERS PRESENTED
11.
Hurvitz, 3.5.; Harrison, M.D.; Weitzman, 3.3.: Aneurysmal Bone Cyst Mimicking Ewing’s Sarcoma of the
Rib. American Pediatric Association Eighth Annual Meeting, Acapulco, Mexico, April 20-23, 1977.
12.
Puckett, L..; Hurvitz, J.S.; Metzler, M.; and Silver, D.: Studies of Bone Formation
ByMicrorevascularizedPeriosteum Compared With Traditional Bone Grafts. 64th Annual Clinical
Congress 1978, American College of Surgeons, Surgical Forum, San Francisco.
13.
Puckett, 0.1..; Hurvitz, J.S.; and Metzler, M.A.: Comparative Evaluation of Bone Formation by
MicrorevascularizedPeriosteum and Bone Grafts. 49th Annual Convention of the American Society of
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 29
Plastic and Reconstructive Surgeons, Plastic Surgery Educational Foundation, and the American Society
of Maxillofacial Surgeons, 1980.
14.
Puckett, C.L.; Hurvitz, J.S.; Metzler, M.; and Silver, D.: Evaluation of Bone Formation by
MicrorevascularizedPeriosteum and Bone Grafts Compared With Traditional Bone Grafts. World Micro—
surgical Congress, Bonn, Germany, 1978.
15.
Puckett, C.L.; Hurvitz, J.S.; Jacobs, G.R.; Hurvitz, J.S.; and Silver, D.: Evaluation of Lymphovenous
Anastomoses in Obstructive Lymphedema. Annual Meeting, Missouri Chapter, American College of
Surgeons, June, 1979.
16.
Hurvitz, J.S.: Efficacy of Hyaluronidase Augmented Interstitial Diffusion (AID) for the Treatment of
Ischemic Flaps. National Student Research Forum, April 18-30, 1982, Galveston, Texas.
17.
Hurvitz, J.S.: Efficacy of Transcutaneous p02 Monitoring for the Assessment of Flap Viability. National
Student Research Forum, April 28-30, 1982, Galveston, Texas.
18.
Hurvitz, J.S: Efficacy of Hyaluronidase Injection Therapy (HIT) for the Treatment of Extravasation Injuries
in Infants. Plastic Surgery Senior Resident Conference, May, 1982, Norfolk, Virginia.
C. VIDEOTAPE, EXHIBIT AND DISPLAY PRESENTATIONS
19.
Hurvitz, J.S.; Blackwell, 5.3.; Lewis, S.R.: VIDEOTAPE PRESENTATION: Composite Tissue Reconstruction of
a Patient With Electrical Injuries to All Four Extremities. American Society of Plastic and Reconstructive
Surgeons, Plastic Surgery Education Foundation and the American Society of Maxillofacial Surgeons, 51st
Annual Meeting.Honolulu, Hawaii, October 10-15, 1982.
20.
Hurvitz, J.S.: SCIENTIFIC EXHIBIT: Computer Assisted Interactive (CAl) Video Programs: Applications in
Plastic Surgery Practice. American Society of Plastic and Reconstructive Surgeons, Plastic Surgery
Educational Foundation and the American Society of Maxillofacial Surgeons 52nd Annual Meeting.
Dallas, Texas, October 30-November 4, 1983.
21.
Hurvitz, J.S.: SCIENTIFIC EXHIBIT: The Super Duper -A New Automated Slide Duplication System.
American Society of Plastic and Reconstructive Surgeons, Plastic Surgery Educational Foundation and
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 30
the American Society of Maxillofacial Surgery Annual Meeting. Dallas, Texas, October 30 – November 4,
1983.
22.
Hurvitz, J.S.: EDUCATIONAL DISPLAY: Efficacy of Transcutaneous p02 Monitoring for the Assessment of
Flap Viability. American Society of Plastic and Reconstructive Surgeons, Plastic Surgery Educational
Foundation and the American Society of Maxillofacial Surgeons Annual Meeting. Dallas, Texas, October
30 -November 4, 1983.
23.
Hurvitz, J.S: EDUCATIONAL DISPLAY: Efficacy of Hyaluronidase Augmented Interstitial Diffusion (AID) for
the Treatment of Ischemic Flaps. American Society of Plastic and Reconstructive Surgeons, Plastic
Surgery Educational Foundation and the American Society of Maxillofacial Surgeons Annual Meeting.
Dallas, Texas, October 30 -November 4, 1983.
24.
Hurvitz, J.S. SCIENTIFIC EXHIBIT: Computer Assisted Video Digitizer Graphics (CA—VDG) Programs:
Applications in Plastic Surgery Practice. 1984 American Society of Plastic and Reconstructive Surgeons,
Plastic Surgery Educational Foundation and the American Society of Maxillofacial Surgeons Annual
Meeting. Las Vegas, Nevada, October, 1984.
25.
Hurvitz, J.S.: SCIENTIFIC EXHIBIT: The Slide Copy System. 1984 American Society of Plastic and
Reconstructive Surgeons, Plastic Surgery Educational Foundation and the American Society of
Maxillofacial Surgeons Annual Meeting. Las Vegas, Nevada, October, 1984.
26.
Hurvitz, J.S.: SCIENTIFIC EXHIBIT: Tourniquet—Nonclamp Technique (TNT) for
Composite Tissue Transfer to the Upper and Lower Extremities. 1984 American Society of Plastic and
Reconstructive Surgeons, Plastic Surgery Educational Foundation and
the American Society of Maxillofacial Surgeons Annual Meeting. Las Vegas, Nevada, October, 1984.
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 31
OTHER CLINICAL STUDIES AND RESEARCH
1. Chemical Peel: Why do You have to peel? Summary:
My work to date has proven that one does not have to peel to obtain improvement in the skin. To be
sure, it has been shown that the term ‘peel’ results from the fact that peeling was originated by lay
practitioners who used caustic chemicals that resulted in a burn that peeled.
After the inflammation, burn and peeling subsided they noted improvement in skin texture and color.
They assumed that the peeling of skin was necessary.
When about forty years ago plastic surgeon Tom Baker MD obtained some of the secret solution from a
lay practitioner, he analyzed the solution. Next he used the solution in the same manner as the lay
practitioners. He assumed that peeling of the skin was necessary without any scientific investigation.
Just because the lay practitioners said it was needed.
Sometimes, it is important to question the reason why authorities say something is needed. Such has
been the case with the idea that it is necessary for the skin to peel to actually get improvement. I have
shown that this is not necessarily so in a series of clinical patients.
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 32
2. Chemical Peel: Where did it come from? Summary:
Lay practitioners originated chemical peeling. One such original chemical lay peeler is the mother of a
famous American actor: the mother of Sylvester Stallone, believe it or not. To be sure, it has been
shown that the term ‘peel’ results from the fact that peeling was originated by lay practitioners who
used caustic chemicals that resulted in a burn that peeled. After the inflammation, burn and peeling
subsided they noted improvement in skin texture and color. They assumed that the peeling of skin was
necessary.
3. Why Do A Peel After A facelift?
Summary :
It was always dogma not to peel before a face lift, but to peel after, and not immediately after. This did
not make sense to me. One of the effects of peeling was shrinking skin. It seemed logical to shrink the
skin first with the peeling process, and then do facelift. It seemed possible to in fact shrink the skin with
peel so that no skin resection is needed.In clinical cases I have peeled first (without harsh peeling and
the need to actually peel after inflammation) and then performed facelift without skin resection with
suspension technique, plus nasal surgery and minimal suction in less than 3 hours under local
anesthesia, in one operation.
4. Why You Have To Remove Skin During A facelift?
Summary:
In short you do not have to remove skin if you shrink the skin first. I have done this repeatedly on
patients.
5. Why Can’t You Do A Facelift, Brow lift, Eye Surgery And Nasal Surgery At The Same Time In Three
Hours Or Less?
Summary:
No reason you cannot. This is what I do routinely.
6. Why Does Cosmetic Surgery Cost So Much?
Summary:
It usually costs so much because of multiple long procedures under general anesthesia and
paying for the plastic surgeons time as well as the anesthesiologists time as well as the cost of the
operating room facility. If you do shorter procedures under local anesthesia, as I have demonstrated
with one operating procedure, the savings can be passed on to the patient.
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 33
7. If Cosmetic Surgery Were Cheaper, Took Less Time and More Areas Of Face Could Be Corrected with
Less Morbidity Would Not Patients Rush To Your Office?
Summary:
Absolutely. This is what I have found. Patients came locally as well as from across the country.
CONTINUING MEDICAL EDUCATION
The CME Tracker automatically logs any Medscape CME and CE activities completed online; it may also
include external activities that have been manually entered by participants.
Medscape CME Activities:
AMA PRA category 1 credits Completion Date Accredited Provider Credits
Highlights From the Summit on HBV Resistance October 15, 2004 Northwestern University, Feinberg
School of Medicine – HealthMatters Communications 1.5
Diagnosis, Pathophysiology, and Treatment of Irritable Bowel Syndrome October 15, 2004 Medscape
Targeting TNF: The Evolution of Biologic Therapy for the Treatment of RA and
SpondyloarthropathiesOctober 15, 2004 TheUniversity of Wisconsin Medical School – Discovery
International 2.5
Implications of Preserving Long-term Renal Function After Renal Transplantation: Epidemiology of Renal
Dysfunction and Cardiovascular Disease October 15, 2004 University of Minnesota 1
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 34
6th International Conference on Malignancies in AIDS &Other Immunodeficiencies – Basic Science
October 15, 2004 The National Institutes of Health/Foundation for Advanced Education in the Sciences
(NIH/FAES) 1
Highlights of the American Society of Pediatric Hematology/Oncology 17th Annual Meeting October 15,
2004 Medscape 1.25
Neuraxial Analgesia by Intrathecal Drug Delivery for Chronic Noncancer Pain October 15, 2004
Medscape 1
Targeting the HER and VEGF Pathways in the Treatment of Cancer October 15, 2004 Medscape 1
Highlights of the XIV European Meeting on HypertensionOctober 15, 2004 Medscape 0.75
Pain Management — Beyond the Basics: Neurostimulationand Pain Control October 15, 2004 Medscape
1
XV International AIDS Conference – Antiretroviral Therapy: Options, Issues, and Insights October 15,
2004 Medscape 1.25
Highlights of the American Academy of Ophthalmology 2003 Annual Meeting October 15, 2004
Medscape 2
XV International AIDS Conference – HIV Pathogenesis, Novel Targets, and New Drugs October 15, 2004
Medscape 0.75
American Thoracic Society 100th International Conference – Chronic Obstructive Pulmonary Disease
October 15, 2004 Medscape 1.25
How to Engage Employers to Improve the Outcomes of Migraine Sufferers October 15, 2004 The Center
forHealth Care Education 1.75
American College of Gastroenterology 68th Annual Scientific Meeting and Postgraduate Course -AcidRelated Disorders/Advances in Endoscopy October 15, 2004 Medscape 1.5
American Diabetes Association 64th Annual Scientific Sessions – Diabetes and Cardiovascular Disease
October 15, 2004 Medscape 1.25
American Society of Hematology 45th Annual Meeting – Management of Hematologic Malignancies
October 15, 2004 Medscape 2
Highlights of the 2004 Gastrointestinal Cancers Symposium October 15, 2004 Medscape 1.5
XV International AIDS Conference – Complications of Antiretroviral Therapy October 15, 2004 Medscape
0.75
Highlights of the 2nd Joint Scientific Meeting of the American Pain Society and the Canadian Pain Society
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 35
October 14, 2004 American Pain Society 1.5
Highlights of the American College of Allergy, Asthma & Immunology 2003 Annual Meeting October 14,
2004 Medscape 1
11th Conference on Retroviruses and Opportunistic Infections – Prevention and Management of HIV
Infection in Children October 14, 2004 Medscape 1
Selective Costimulation Modulators: Addressing Unmet Needs in Rheumatoid Arthritis Management
October 14, 2004 Health Science Center 1
IBS: Improving Diagnosis, Serotonin Signaling, and Implications for Treatment October 14, 2004
Medscape 1.5
Acne Comes of Age: Treatment Approaches for the Adult Population October 14, 2004 Medscape 1.25
American College of Cardiology Annual Scientific Session 2004 – Cardiac Imaging October 14, 2004
Medscape 1
American Heart Association Scientific Sessions 2003 – Noninvasive Imaging October 14, 2004 Medscape
0.75
Therapeutic Options for External Genital Warts October 14, 2004 Medscape 0.5 Module I.
Macronutrients October 14, 2004 Medscape 1
Endometriosis and Infertility October 14, 2004 Medscape 1
Improving Screening of Women for Violence –Basic Guidelines for Physicians October 14, 2004
Medscape 1
American Academy of Family Physicians 2003 Scientific Assembly – Osteoporosis and Headache AAFP
October 14, 2004 Medscape-AAFP 1
Module II. Micronutrients October 14, 2004 Medscape 1.75
Restoring Sexual Desire: The Safety and Efficacy of Testosterone in Menopausal Women October 14,
2004 Discovery International 2
Exploring the True Morbidity of Insomnia October 14, 2004 The Center for Health Care Education 2
Interventional Management of Cancer Pain October 14, 2004 Medscape 1
Pharmacokinetic Interactions of Immunosuppressive Agents After Organ Transplantation October 14,
2004 Medscape 1
Smoking Cessation Approaches for Primary Care October 14, 2004 Medscape 1.5
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 36
Highlights of the International Congress of Biological Psychiatry October 14, 2004 Medscape 3.5
The Expanding Role of Antipsychotic Pharmacotherapy inBipolar Disorder October 14, 2004 Medscape 1
Selecting Appropriate IGIV Therapy October 14, 2004 Medical Education Resources 1
Whole-Body Screening MRI: What You and Your Patients Should Know October 14, 2004 Medscape 0.5
The Obesity and Diabetes Epidemic: The State of the Science and the Challenge to Public Health October
14, 2004 Medscape 1
Closing Session – APHA 131st Annual Meeting October 14, 2004 Medscape 1.25
American Society for Bone and Mineral Research 25thAnnual Meeting – Highights of the American
Society for Bone and Mineral Research 25th Annual Meeting October 14, 2004 Medscape 2.5
Highlights of the World Allergy Organization Congress — XVIII ICACI October 14, 2004 Medscape 1
Highlights of the 89th Annual Scientific Assembly and Annual Meeting of the Radiological Society of
North America October 14, 2004 Medscape 1.25
American Thoracic Society 100th International Conference – Pulmonary Critical Care Challenges
October 14, 2004 Medscape 0.75
Highlights of the American Academy of Allergy, Asthma & Immunology 60th Annual Meeting October 14,
2004 Medscape 1.25
Update in Hormonal Therapy: A 2004 Perspective October 14, 2004 Physicians’ Education Resource
Chapter 1: Detection, Diagnosis, and Prognosis of Prostate Cancer October 14, 2004 Medscape-PCF
1.25
Pharmacokinetic/Pharmacodynamic Considerations of Once-Daily Dosing of Antiretroviral Drugs
October 14, 2004 Medscape 1
HIV Drug Resistance and Clinical Pharmacology October 14, 2004 Medscape 1.5
American Society of Clinical Oncology 2004 Annual Meeting – Management of Lung Cancer October 14,
2004 Medscape 1.25
“Confusion” in a 9-Year-Old Child October 14, 2004 Medscape 1
Temporal Lobe Epilepsy: The Current State of Knowledge October 14, 2004 The American Epilepsy
Society 2
Converting Epilepsy Polytherapy to Monotherapy Step by Step October 14, 2004 Medscape 1
New Visions for Insomnia: Evolving Insights and Emerging Directions October 14, 2004 Academy for
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 37
Healthcare Education 2
Highlights of the American Epilepsy Society 57th Annual Meeting October 14, 2004 The American
Epilepsy Society 1.5
From Targets to Therapy: Novel Drugs in Advanced Clinical Trials October 14, 2004 University of
Nebraska Medical Center – CCE – Health Science Center for Continuing Medical Education 2
Challenges in Crohn’s Disease: The Role for Current and Future TNF Antagonists October 14, 2004
Chicago Medical School at Rosalind Franklin U of Medicine – Science and Scientific Frontiers, Inc 2
Can Interstitial Cystitis Overlap With Nonbacterial Prostatitis? Diagnosis and Misdiagnosis October 14,
2004 Postgraduate Institute for Medicine 1
Chapter 8: Nutrition and Prevention Strategies for Prostate Cancer October 14, 2004 Medscape-PCF
1
Highlights of 25th Annual Scientific Meeting of the American Urogynecology Society and the 30th
Annual Meeting of the Society of Gynecologic Surgeons October 14, 2004 Medscape 0.5
Women’s Sexual Problems – A Guide to Integrating the “New View” Approach October 14, 2004
Medscape 2
Patient Issues in the Treatment of Erectile Dysfunction October 14, 2004 Medscape 0.5
Chapter 3: Androgen Deprivation Therapy for Prostate Cancer October 14, 2004 Medscape-PCF 1
Management of Posttransplant Malignancies October 14, 2004 Medscape 1
Highlights of the American Society for Therapeutic Radiology and Oncology 45th Annual Meeting
(ASTRO) October 14, 2004 Medscape 0.75
XV International AIDS Conference – Opportunistic Infections and Coinfections October 14, 2004
Medscape 0.75
Highlights of the European Society of Intensive Care Medicine 16th Annual Congress October 14, 2004
Medscape 1.5
Highlights of the 33rd Critical Care Congress of the Society of Critical Care Medicine (SCCM) October 14,
2004 Medscape 1.75
Highlights of CHEST 2003: 69th Annual Meeting of the American College of Chest Physicians October 14,
2004 Medscape 3
Advances in Osteoarthritis Research: Investigating Subchondral Bone as Etiologic Agent and Therapeutic
Target October 14, 2004 Medscape 1
The Essentials of Fundamental Skin Care: Scientific Rationale and Clinical Applications October 14, 2004
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 38
Postgraduate Institute for Medicine 1
The Epidemic of Nonmelanoma Skin Cancer: Prevention, Diagnosis, and Treatment October 14, 2004
Medscape 1
The Aging Face: More Than Skin Deep October 14, 2004 Discovery International 2.5
Advances in OAB Therapy: The Promise of M3-Selective Antimuscarinic Therapy for Optimal Patient
Management October 14, 2004 Medical Education Collaborative 1.5
Chapter 5: Chemotherapeutic Options in Prostate Cancer October 14, 2004 Medscape-PCF 1
Chapter 7: Management of Side Effects of Prostate Cancer Therapy October 14, 2004 Medscape-PCF
1.5
Long-term Dietary Interventions: Effects on Weight Loss and Health (Web Conference) October 14, 2004
Medscape 1
Current Perspectives in Insomnia, Volume 3 October 14, 2004 Medscape 1
American Transplant Congress 2004 –Immunosuppression in an Era of Less Is More October 14, 2004
Medscape 1.25
Highlights of the American Public Health Association131st Annual Meeting October 14, 2004 Medscape3
Society of Nuclear Medicine 50th Annual Meeting – Highlights from the Society of Nuclear Medicine 50th
Annual Meeting October 14, 2004 Society of Nuclear Medicine 2
6th International Conference on Malignancies in AIDS &Other Immunodeficiencies – Clinical Science
October 14, 2004 The National Institutes of Health/Foundation for Advanced Education in the Sciences
(NIH/FAES) 1
New Horizons in TNF Inhibition – Topic 1: Treating Ankylosing Spondylitis October 14, 2004 Discovery
International 1
New Horizons in TNF Inhibition – Topic 2: Targeting Psoriatic Arthritis October 14, 2004 Discovery
International 1
Managing Infections in Patients With Hematologic Malignancies October 13, 2004 Academy for
Healthcare Education 1.5
Emergency Contraceptive Pills and Adolescents (Live Web Conference) October 13, 2004 American
College of Preventive Medicine 1.5
Gastrointestinal Interactive: Audience-Directed Updates in Acid-Related Disorders October 13, 2004
CME Consultants, Inc. 1.75
Sculpting New Treatment Strategies for High-Risk Patients With Dyslipidemia October 13, 2004 The FCG
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 39
Institute for Continuing Education 1.25
Importance of Asymptomatic Shedding in the Prevention and Treatment of Genital Herpes (Web
Conference) October 13, 2004 Medscape 1
Nucleoside and Nucleotide Reverse Transcriptase Inhibitors in the Treatment of HIV: Focus on Efficacy
October 13, 2004 Discovery International 1.75
Identification and Management of Neurologic and Psychiatric Side Effects Associated With HIV and
HAART October 13, 2004 Discovery International 1.75
Long-term NSAID Use and Acid-Related GI Complications: Improving the Outcomes October 13, 2004
Postgraduate Institute for Medicine 1.25
43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy – Treatment and
Management of HIV/AIDS and Related Conditions October 13, 2004 Medscape 1
Antibiotic Selection for Infections Involving Methicillin-Resistant Staphylococcus aureus October
13, 2004 Medical Education Resources 1
Chapter 9: Therapeutic Strategies for Patients With a Rising PSA: A Case-Based Approach October 13,
2004Medscape-PCF 0.75
Beyond the Mundane: An Update in Acid-Related Disorders October 13, 2004 The Postgraduate Institute
for Medicine – Advantage Communications 1.25
Spicing Up the Controversies and Unraveling the Issues of Acid-Related Disorders October 13, 2004
Rush-Presbyterian-St. Luke’s Medical Center 2
Myths & Misconceptions: Biologic Therapy for Crohn’sDisease October 13, 2004 University of
Pennsylvania School of Medicine 1.5
Optimal Strategies for the Multidisciplinary Management of Prostate Cancer (Web Conference)October
13, 2004 Medscape-PCF 1.5
The Epilepsy Continuum: From Age to Age October 13, 2004 The American Epilepsy Society Medscape 1
Assessment and Management of Childhood and Adolescent Obesity October 13, 2004 Medscape 2
Challenges in the Long-term Management of Patients Post Stent: Harmonizing Medical and
Interventional Therapies October 13, 2004 The University of Michigan Medical School 2
The GI Cancer Challenge: Establishing Treatment Strategies Within the Evolving Paradigm October 13,
2004 Academy for Healthcare Education 2
The Evolving Role of the Surgeon in Back Pain Management: The New Care Continuum October 13, 2004
Medscape 1
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 40
Face-Off: Clinical Counterpoints, New Techniques, and Controversies in Orthopaedic Surgery and Pain
Management October 13, 2004 Albert Einstein College of Medicine 2
Advances in Diabetes for the Millennium: UnderstandingInsulin Resistance October 15, 2004 Medscape
0.5
Advances in Diabetes for the Millennium: Nutritional Therapy of Type 2 Diabetes October 15, 2004
Medscape 0.5
Advances in Diabetes for the Millennium: Drug Therapy of Type 2 Diabetes October 15, 2004 Medscape
0.75
Diagnostic Methods for Insect Sting Allergy October 14, 2004 Medscape 1
Conference Report – Early Cancer Diagnosis: Beating the Odds October 14, 2004 Medscape 1
Carotid Endarterectomy at the Millennium: What Interventional Therapy Must Match October 13, 2004
Medscape 1
AAFP – Reviewed and acceptable for Prescribed credit\hours by the American Academy of Family
Physicians. Total Medscape CME Credits Earned: 152.25 Medscape CME/CE Activities: Letters of
Completion
(LOC)* Completion Date Accredited Provider Credits
Highlights of the 7th Annual Neonatal Advanced Practice Nursing Forum 2004 October 14, 2004
Dartmouth-Hitchcock Medical Center 1.2 Highlights of the National Conference of Gerontological Nurse
Practitioners (NCGNP) 2003 October 14, 2004 Arizona Nurses Association 3.3 Highlights of the National
Association of Neonatal Nurses (NANN)2003 Annual Conference October 14, 2004
National Association of Neonatal Nurses 1 Children’s Health and The Environment: Environmentally
Healthy Homes and Communities October 14, 2004
American Nurses Association 2.8
Total Hours Completed: 8.3
Total Credits Earned: 160.55
Curriculum Vitae
J SandorHurvitz MD
Curriculum Vitae
06.18.2012 Page 41